Four leading insurance companies have recognized Rosecrance’s commitment to providing the highest level of care to clients. These distinctions are designed to help people seeking treatment find quality substance use disorder and mental health programs.
Aetna, Blue Cross and Blue Shield, Cigna, and Optum require healthcare providers to meet criteria focused on quality, evidence-based practices, commitment to improving outcomes, and cost-efficiency in order to earn recognition. Rosecrance received the highest rating awarded by each provider: Aetna’s Institute of Quality, Blue Cross and Blue Shield’’s Blue Distinction Specialty Care program, Cigna’s Center of Excellence, and Optum’s Platinum Status.
According to the Centers for Disease Control and Prevention, 130 Americans die every day from an opioid overdose, which highlights the seriousness of the opioid epidemic and how critical it is for patients to receive comprehensive, meaningful care. In addition, calls to the Substance Abuse and Mental Health Services Administration crisis hotline have significantly increased because of COVID-19-related stress.
“We are extremely grateful that these companies understand and value the work we do every day,” said Rosecrance CEO Phil Eaton. “Being recognized by such respected providers shows that our care is second to none, and it makes it much easier for clients to find hope and healing they deserve.”